Calithera Biosciences Inc
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Calithera Biosciences Inc (CALA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2022: -0.422x
Based on the latest financial reports, Calithera Biosciences Inc (CALA) has a cash flow conversion efficiency ratio of -0.422x as of December 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.60 Million) by net assets ($20.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Calithera Biosciences Inc - Cash Flow Conversion Efficiency Trend (2012–2022)
This chart illustrates how Calithera Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Calithera Biosciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Calithera Biosciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PACIFIC ONLINE
BE:4P7
|
N/A |
|
Ccs
WAR:CCS
|
N/A |
|
SINOPEC SH PETRO-H- - Dusseldorf Stock Exchang
DU:SGJH
|
N/A |
|
Blackrock Smaller Companies Trust PLC
LSE:BRSC
|
0.008x |
|
Da Nang Construction Building Materials Vicem JSC
VN:DXV
|
N/A |
|
Prosperity Weaving Mills Ltd
KAR:PRWM
|
N/A |
|
MCB INDIA SOVEREIGN BOND (FIXED INCOME)-(USD)
SEM:MISB
|
N/A |
|
CREO MEDICAL GRP LS-001
F:1RC
|
N/A |
Annual Cash Flow Conversion Efficiency for Calithera Biosciences Inc (2012–2022)
The table below shows the annual cash flow conversion efficiency of Calithera Biosciences Inc from 2012 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $20.39 Million | $-43.61 Million | -2.138x | +72.96% |
| 2021-12-31 | $8.38 Million | $-66.30 Million | -7.910x | -860.40% |
| 2020-12-31 | $102.37 Million | $-84.31 Million | -0.824x | -48.96% |
| 2019-12-31 | $142.43 Million | $-78.75 Million | -0.553x | -8.04% |
| 2018-12-31 | $126.71 Million | $-64.84 Million | -0.512x | -659.34% |
| 2017-12-31 | $150.31 Million | $13.75 Million | 0.091x | +114.72% |
| 2016-12-31 | $49.91 Million | $-31.02 Million | -0.622x | -49.09% |
| 2015-12-31 | $71.79 Million | $-29.93 Million | -0.417x | -117.61% |
| 2014-12-31 | $100.37 Million | $-19.23 Million | -0.192x | -133.69% |
| 2013-12-31 | $-20.81 Million | $-11.84 Million | 0.569x | -30.26% |
| 2012-12-31 | $-8.57 Million | $-6.99 Million | 0.816x | -- |